Neuropathological autopsy findings after CD19 CAR-T-cell therapy for diffuse large B-cell lymphoma

被引：0
|
作者：
Champion, Samantha [1 ]
Martinez-Lage, Maria [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1630
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neuropathological autopsy findings after CD19 CAR-T- cell therapy for diffuse large B-cell lymphoma
    Champion, Samantha
    Martinez-Lage, Maria
    MODERN PATHOLOGY, 2019, 32
  • [2] Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss
    Bukhari, Ali
    El Chaer, Firas
    Koka, Rima
    Singh, Zeba
    Hutnick, Elizabeth
    Ruehle, Kathleen
    Lee, Seung Tae
    Kocoglu, Mehmet H.
    Shanholtz, Carl
    Badros, Ashraf
    Hardy, Nancy
    Yared, Jean
    Rapoport, Aaron P.
    Dahiya, Saurabh
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (10) : E273 - E275
  • [3] Signatures of response to CD19 CAR-T-cells in diffuse large B-cell lymphoma
    Ohlmeier, Luisa
    Loeber, Jens
    Grunert, Corinna
    Busse, Antonia
    Chapuy, Bjoern
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 793 - 793
  • [4] Genomic Drivers of Large B-Cell Lymphoma Resistance to CD19 CAR-T Therapy
    Jain, Michael D.
    Ziccheddu, Bachisio
    Coughlin, Caroline A.
    Faramand, Rawan
    Griswold, Anthony J.
    Reid, Kayla M.
    Landgren, Ola
    Locke, Frederick L.
    Maura, Francesco
    Davila, Marco L.
    Schatz, Jonathan H.
    BLOOD, 2021, 138
  • [5] GENOMIC DRIVERS OF LARGE B-CELL LYMPHOMA RESISTANCE TO CD19 CAR-T THERAPY
    Jain, Michael
    Ziccheddu, Bachisio
    Coughlin, Caroline
    Faramand, Rawan
    Griswold, Anthony
    Reid, Kayla
    Landgren, Ola
    Locke, Frederick
    Maura, Francesco
    Davila, Marco
    Schatz, Jonathan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A703 - A703
  • [6] Clinical Outcomes of CD19 CAR-T-Cell Therapy with Axi-Cel in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) with and without Prior Autologous Stem Cell Transplant
    Chen, David Tong
    Goloubeva, Olga
    Alkhaldi, Hanan
    Rapoport, Aaron P.
    Dahiya, Saurabh
    Hardy, Nancy M.
    Atanackovic, Djordje
    Kocoglu, Mehmet Hakan
    Lutfi, Forat
    Yared, Jean A.
    BLOOD, 2022, 140 : 9526 - 9527
  • [7] CD19 CAR T-cell therapy for relapsed/refractory diffuse large B-cell lymphoma (DLBCL) - the Munich Real Life Experience
    Buecklein, V.
    Schmidt, C.
    Blumenberg, V.
    Reischer, A.
    von, Baumgarten L.
    Voelkl, A.
    Wagner, B.
    Humpe, A.
    Reilich, S.
    Bauer, M.
    Ostermann, H.
    Tischer, J.
    Stemmler, H-J.
    von Bergwelt, M.
    Subklewe, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 80 - 81
  • [8] CAR T-cell therapy in diffuse large B-cell lymphoma
    Hopfinger, Georg
    Worel, Nina
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (01) : 32 - 35
  • [9] CAR T-cell therapy in diffuse large B-cell lymphoma
    Georg Hopfinger
    Nina Worel
    memo - Magazine of European Medical Oncology, 2020, 13 : 32 - 35
  • [10] CD19 CAR-T cell therapy for relapsed or refractory diffuse large B cell lymphoma: Why does it fail?
    Kinoshita, Hannah
    Bollard, Catherine M.
    Toner, Keri
    SEMINARS IN HEMATOLOGY, 2023, 60 (05) : 329 - 337
12345